Genenta Science stock plunges after $15 million ADS offering By Investing.com
Update: 2025-10-27
Description
Genenta Science stock plummets 42% after announcing a $15 million share offering to raise capital, diluting current shareholder value. The deal, led by Maxim Group, prices shares at $3.50 each, significantly below market value, sparking investor concern despite the funding being earmarked for working capital and ongoing operations. Will this cash injection fuel Genenta's cancer research or further erode investor confidence?
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
